Form 8-K ARROWHEAD PHARMACEUTICAL For: Jun 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Arrowhead Pharmaceuticals appoints Dr. Matt Cohen to its board of directors
June 16, 2026 4:07 PM EDTArrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) announced that its Board of Directors appointed Dr. Matt Cohen, M.D., M.B.A., as a director of the company, effective June 12, 2026.
Dr. Cohen currently serves as Managing Director at Vida Ventures, a position he... More
